While Ozempic is FDA-approved for type 2 diabetes and offers added weight loss benefits, compounded semaglutide lacks FDA approval and is no longer widely available following the resolution of a semaglutide shortage in March 2025
Maximum 8 doses in 24 hours
The administration of exogenous GLP-1 analogs is demonstrated to promote long-term weight loss in obese patients [4, 5]
Protects the heart Reply 5 people found this helpful
Oral minoxidil is an option if topical isnt tolerated this requires doctor supervision and isnt available from most trichologists
Ideal Patient Profile and Independent Review At a glance Business model / cash-pay compounding pharmacy with telehealth prescribing Core drug categories / GLP-1 receptor agonists, peptides, HRT (testosterone, estradiol, progesterone) Primary patient fit / adults with BMI 30+ (or 27+ with comorbidity) seeking obesity pharmacotherapy without insurance GLP-1 evidence base / semaglutide 2.4 mg showed 14.9% mean weight loss vs